Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia

Clinical Microbiology and Infection

Volumn 16, Issue 12, 2010, Pages 1783-1788

  Nagao, M ^a,b   Iinuma, Y ^a,b   Saito, T ^c   Matsumura, Y ^a,b   Shirano, M ^a,b   Matsushima, A ^a,b   Takakura, S ^a,b   Ito, Y ^a,b   Ichiyama, S ^a,b  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Shiga Medical Center for Adults   (Japan)

Author keywords

Bacteraemia; Intervention; Outcome; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; HABEKACIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; ECHOCARDIOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; STAPHYLOCOCCAL BACTEREMIA; TREATMENT OUTCOME;

STAPHYLOCOCCUS AUREUS;

EID: 78349296369     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03156.x     Document Type: Article

References (22)

1. Fowler VG Jr, Sanders LL, Sexton DJ et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998; 27: 478-486.
2. Classen DC, Burke JP, Wenzel RP. Infectious diseases consultation: impact on outcomes for hospitalized patients and results of a preliminary study. Clin Infect Dis 1997; 24: 468-470.
3. Kaech C, Elzi L, Sendi P et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006; 12: 345-352.
4. Ebnother C, Tanner B, Schmid F et al. Impact of an infection control program on the prevalence of nosocomial infections at a tertiary care center in Switzerland. Infect Control Hosp Epidemiol 2008; 29: 38-43.
5. Uckay I, Vernaz-Hegi N, Harbarth S et al. Activity and impact on antibiotic use and costs of a dedicated infectious diseases consultant on a septic orthopaedic unit. J Infect 2009; 58: 205-212.
6. Fluckiger U, Zimmerli W, Sax H et al. Clinical impact of an infectious disease service on the management of bloodstream infection. Eur J Clin Microbiol Infect Dis 2000; 19: 493-500.
7. Botelho-Nevers E, Thuny F, Casalta JP et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med 2009; 14: 1290-1298.
8. Takakura S, Fujihara N, Saito T et al. Improved clinical outcome of patients with Candida bloodstream infections through direct consulatation by infectious diseases physicians in a Japanese University hospital. Infect Control Hosp Epidemiol 2006; 27: 964-968.
9. Hill PC, Birch M, Chambers S et al. Prospective study of 424 cases of Staphylococcus aureus bacteremia: determination of factors affecting incidence and mortality. Intern Med J 2001; 31: 97-103.
10. Jenkins TC, Price CS, Sabel AL et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008; 46: 1000-1008.
11. Jenkins TC, Burman WJ. Reply to Yamamoto and Iwata. Clin Infect Dis 2008; 47: 432-433.
12. Durack DT, Lukes AS, Bright DK; Duke Endocarditis Service. New criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 4: 633-638.
13. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000; 3: 238.
14. Mermel LA, Farr BM, Sherertz RJ et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 2001; 32: 1249-1272.
15. Fowler VG Jr, Boucher HW, Corey GR et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-665.
16. Boucher HW, Corey GR, Forrest G et al. Length of therapy and outcome in S. aureus bacteremia and endocarditis: less than 14 days of therapy is associated with lower success rates in uncomplicated S. aureus bacteremia [abstract 367]. In: Programs and abstracts of the 44th Annual Meeting of the Infectious Diseases Society of America (Toronto, Canada). Arlington, VA: Infectious Diseases Society of America, 2006; 115.
17. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59.
18. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1995; 21: 1417-1423.
19. Soriano A, Martinez JA, Mensa J et al. Pathogenic significance of methicillin-resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 2000; 30: 368-373.
20. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. Outcome analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36: 1418-1423.
21. Corey GR. Staphylococcus aureus bloodstream infections: definition and treatment. Clin Infect Dis 2009; 48: S254-S259.
22. Mermel LA, Allon M, Bouza E et al. Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45.